Myopic defocus via optical segment-induced retinal image manipulation

The phrase "Myopic defocus via optical segment-induced retinal image manipulation" refers to the deliberate induction of myopic (positive) defocus onto the retina using optical methods such as specialized spectacle lenses (e.g. "multifocal" or "segmented" lenses), contact lenses, or other devices. This creates focal planes in the peripheral or global retina that are in front of the photoreceptors, altering retinal signaling and reducing axial eye growth. The approach is used as a therapeutic strategy to counter myopia progression and is based on evidence that the retina, particularly the peripheral retina, responds to imposed defocus signals by initiating biochemical signaling cascades (dopaminergic, retinoic acid, nitric oxide, BMP pathway) that regulate scleral remodeling and coordinate eye growth[7][3][5]. Optical myopic defocus itself is not a molecule, receptor, or drug target, but an imposed visual stimulus; it acts as a non-pharmacologic cue to guide emmetropization and control myopia development. If you need information about actual molecular, receptor, or enzyme targets involved in the biological responses to myopic defocus (e.g., BMP signaling pathways, dopamine receptors in the retina), please clarify so specific biochemical or therapeutic targets can be detailed.

Other names

Myopic optical defocusPeripheral myopic defocusRetinal myopic defocusOptical segment-induced defocus

Mechanism is optical, not molecular; no drugs act on it directly.